The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Open accessAbstract
The syndrome of microangiopathic hemolysis associated with renal failure, neurologic impairment, or both is a recognized complication of hematopoietic stem cell transplantation. This entity is often called hemolytic uremic syndrome (HUS) or thrombotic thrombocytopenic purpura (TTP), yet it is clear that the pathophysiology of transplant-associated HUS/TTP is different from that of classic HUS or TTP. Furthermore, the incidence of this syndrome varies from 0.5% to 76% in different transplant series, primarily because of the lack of a uniform definition. The toxicity committee of the Blood and Marrow Transplant Clinical Trials Network has reviewed the current literature on transplant-related HUS/TTP and recommends that it be henceforth renamed posttransplantation thrombotic microangiopathy (TMA). An operational definition for TMA based on the presence of microangiopathic hemolysis and renal and/or neurologic dysfunction is proposed. The primary intervention after diagnosis of TMA should be withdrawal of calcineurin inhibitors. Plasma exchange, although frequently used in this condition, has not been proven to be effective. In the absence of definitive trials, plasma exchange cannot be considered a standard of care for TMA. It is hoped that these positions will improve the identification and reporting of this devastating complication after hematopoietic stem cell transplantation and facilitate future clinical studies for its prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
George, J. N., Li, X., McMinn, J. R., Terrell, D. R., Vesely, S. K., & Selby, G. B. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.00700.x · Cited by 246
Fuge, R., Bird, J. M., Fraser, A., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02699.x · Cited by 143
Matsuda, Y., Hara, J., Miyoshi, H., Osugi, Y., Fujisaki, H., Takai, K., Ohta, H., Tanaka‐Taya, K., Yamanishi, K., & Okada, S. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702003 · Cited by 75
Sarkodee-Adoo, C. B., Sotirescu, D., Sensenbrenner, L., et al. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00282.x · Cited by 65
Maslo, C., Péraldi, M., Desenclos, J. C., Mougenot, B., Cywiner-Golenzer, C., Chatelet, F.-P., Jacomet, C., Rondeau, É., Rozenbaum, W., & Sraer, J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.350 · Cited by 63
Mechanism of Aspergillus-Induced Microangiopathic Hemolytic Anemia
Robboy, S. J. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.128.5.790 · Cited by 29
Kok, R. H. J., Wolfhagen, M. J. H. M., & Klosters, G. (2001) · Clinical Infectious Diseases · doi:10.1086/318481 · Cited by 29
Grigg, A., & Clouston, D. R. (1995) · PubMed · Cited by 21
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Thrombotic Thrombocytopenic Purpura
(2006) · New England Journal of Medicine · doi:10.1056/nejmc061483 · Cited by 573
Leen, A. M., Bollard, C. M., Mendizabal, A. M., Shpall, E. J., Szabolcs, P., Antin, J. H., Kapoor, N., Pai, S.-Y., Rowley, S. D., Kebriaei, P., et al. (2013) · Blood · doi:10.1182/blood-2013-02-486324 · Cited by 553
Szczepiorkowski, Z. M., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Shaz, B. H., Weinstein, R., Wirk, A., et al. (2007) · Journal of Clinical Apheresis · doi:10.1002/jca.20129 · Cited by 546
Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Weinstein, R., & Shaz, B. H. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20240 · Cited by 508
Thrombotic Thrombocytopenic Purpura
George, J. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp053024 · Cited by 485
How I treat patients with thrombotic thrombocytopenic purpura: 2010
George, J. N. (2010) · Blood · doi:10.1182/blood-2010-07-271445 · Cited by 469
Ruutu, T., Barosi, G., Benjamin, R. J., Clark, R. E., George, J. N., Gratwohl, A., Holler, E., Iacobelli, M., Kentouche, K., Lammle, B., et al. (2007) · Haematologica · doi:10.3324/haematol.10699 · Cited by 395
Kakihana, K., Fujioka, Y., Suda, W., Najima, Y., Kuwata, G., Sasajima, S., Mimura, I., Morita, H., Sugiyama, D., Nishikawa, H., et al. (2016) · Blood · doi:10.1182/blood-2016-05-717652 · Cited by 367
Jodele, S., Laskin, B. L., Dandoy, C. E., Myers, K. C., El-Bietar, J., Davies, S. M., Goebel, J., & Dixon, B. P. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.11.001 · Cited by 353
Laskin, B. L., Goebel, J., Davies, S. M., & Jodele, S. (2011) · Blood · doi:10.1182/blood-2011-02-321315 · Cited by 315
Atypical aHUS: State of the art
Nester, C. M., Barbour, T., de Cordoba, S. R., Dragon-Durey, M. A., Fremeaux-Bacchi, V., Goodship, T. H. J., Kavanagh, D., Noris, M., Pickering, M., Sanchez-Corral, P., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.246 · Cited by 299
Jodele, S., Licht, C., Goebel, J., Dixon, B. P., Zhang, K., Sivakumaran, T. A., Davies, S. M., Pluthero, F. G., Lu, L., & Laskin, B. L. (2013) · Blood · doi:10.1182/blood-2013-05-501445 · Cited by 253
Gavriilaki, E., Anagnostopoulos, A., & Mastellos, D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00337 · Cited by 106
Metadata
- Authors
- Ho, V. T., Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., Ferrara, J., Soiffer, R., & Giralt, S.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 11
- Issue
- 8
- Pages
- 571-575
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2085290177
- Cited by
- 460
- References
- 8
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.